355 filings
Page 4 of 18
8-K
ctpjn
24 Aug 20
Other Events
6:16am
8-K
jx3o6tw5d ie
19 Aug 20
Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients
6:20am
8-K
ferenm2vvs3
14 Aug 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
40e26trskda44x6wub
13 Aug 20
Entry into a Material Definitive Agreement
5:15pm
8-K
v0l5 opt5sstsoz
3 Aug 20
Entry into a Material Definitive Agreement
8:43am
8-K
ukohxec0os8q4w1f65jb
29 Jul 20
Mateon Therapeutics Closes $2.0 Million Financing
5:14pm
8-K
6fontzpjx
18 Jun 20
Other Events
10:30am
8-K
tvs9v2f th
16 Jun 20
Mateon Announces Achievement of Milestone Under Licensing of OT-101/IL-2 Combination to Autotelic Bio
6:58am
8-K
u28bqulz5df2mw9v
12 Jun 20
Mateon Announces an Expansion to Its Pharmaceutical Manufacturing Ai Camera Grid by Including Contact Tracing to Ensure Worker Safety
9:00am
8-K
wp5 zzj0pogdq
14 May 20
Departure of Directors or Certain Officers
5:22pm
8-K
8p2nswcu3l 1a3zk
12 May 20
Mateon Provides Update on its R&D Effort Against COVID-19
10:56am
8-K
0yy74upder4gq tp6z
11 May 20
Other Events
8:18am
8-K
2sfyle kma
4 May 20
Other Events
9:00am
8-K
nphdiqwhj
29 Apr 20
Other Events
6:18am
8-K
kyl7d4g0jbpeemlk5 92
27 Apr 20
Entry into a Material Definitive Agreement
2:46pm
8-K
w1f2raely ily8j
24 Apr 20
Other Events
6:15am
8-K
87uvyt
20 Apr 20
Regulation FD Disclosure
6:15am
8-K
cqc1w4fmrj2 1u8v0oi8
14 Apr 20
Other Events
1:03pm
8-K
9gt11
14 Apr 20
Mateon Achieves Milestone In Its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
6:16am
8-K
bohfoq
7 Apr 20
Other Events
3:00pm